57 related articles for article (PubMed ID: 26650459)
21. In Reply.
Kertai MD; Zhou S; Karhausen JA; Cooter M; Jooste E; Li YJ; White WD; Aronson S; Podgoreanu MV; Gaca J; Welsby IJ; Levy JH; Stafford-Smith M; Mathew JP; Fontes ML
Anesthesiology; 2016 Aug; 125(2):438-9. PubMed ID: 27433767
[No Abstract] [Full Text] [Related]
22. Altered plasma fibrin clot properties in essential thrombocythemia.
Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
[TBL] [Abstract][Full Text] [Related]
23. Cross-talk between inflammation,coagulation/fibrinolysis and vascular access in hemodialysis patients.
Costa E; Rocha S; Rocha-Pereira P; Castro E; Reis F; Teixeira F; Miranda V; Do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
J Vasc Access; 2008; 9(4):248-53. PubMed ID: 19085894
[TBL] [Abstract][Full Text] [Related]
24. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
25. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.
Kaminski TW; Pawlak K; Karbowska M; Mysliwiec M; Grzegorzewski W; Kuna J; Pawlak D
Int Urol Nephrol; 2018 Jan; 50(1):127-135. PubMed ID: 29058166
[TBL] [Abstract][Full Text] [Related]
26. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
27. Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease.
Mörtberg J; Blombäck M; Wallén Å; He S; Jacobson SH; Spaak J
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):401-7. PubMed ID: 26650459
[TBL] [Abstract][Full Text] [Related]
28. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
29. von Willebrand factor and fibrinogen.
Ruggeri ZM
Curr Opin Cell Biol; 1993 Oct; 5(5):898-906. PubMed ID: 8240833
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic and fibrinolytic factors. A review.
Welles EG
Vet Clin North Am Small Anim Pract; 1996 Sep; 26(5):1111-27. PubMed ID: 8863393
[TBL] [Abstract][Full Text] [Related]
31. Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis.
Memtsas VP; Arachchillage DRJ; Gorog DA
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540604
[TBL] [Abstract][Full Text] [Related]
32. Plasma Protein Carbonyls as Biomarkers of Oxidative Stress in Chronic Kidney Disease, Dialysis, and Transplantation.
Colombo G; Reggiani F; Angelini C; Finazzi S; Astori E; Garavaglia ML; Landoni L; Portinaro NM; Giustarini D; Rossi R; Santucci A; Milzani A; Badalamenti S; Dalle-Donne I
Oxid Med Cell Longev; 2020; 2020():2975256. PubMed ID: 33299524
[TBL] [Abstract][Full Text] [Related]
33. Fibrinogen-fibrin system regulators from bloodsuckers.
Zavalova LL; Basanova AV; Baskova IP
Biochemistry (Mosc); 2002 Jan; 67(1):135-42. PubMed ID: 11841348
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
